GSK3145095   Click here for help

GtoPdb Ligand ID: 12245

Synonyms: compound 6 [PMID: 31223438] | GSK-3145095
PDB Ligand
Compound class: Synthetic organic
Comment: GSK3145095 is an orally bioavailable receptor-interacting serine/threonine-protein kinase 1 (RIPK1) inhibitor [1]. It was developed for potential antineoplastic and immunomodulatory activities, but development was terminated at Phase 2.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 6
Hydrogen bond donors 3
Rotatable bonds 5
Topological polar surface area 99.77
Molecular weight 397.38
XLogP 3.65
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES O=C1Nc2c(CC[C@@H]1NC(=O)c1n[nH]c(n1)Cc1ccccc1)cc(cc2F)F
Isomeric SMILES C1Cc2c(c(cc(c2)F)F)NC(=O)[C@H]1NC(=O)c1n[nH]c(n1)Cc1ccccc1
InChI InChI=1S/C20H17F2N5O2/c21-13-9-12-6-7-15(19(28)25-17(12)14(22)10-13)23-20(29)18-24-16(26-27-18)8-11-4-2-1-3-5-11/h1-5,9-10,15H,6-8H2,(H,23,29)(H,25,28)(H,24,26,27)/t15-/m0/s1
InChI Key ATQAGKAMBISZQM-HNNXBMFYSA-N
References
1. Harris PA, Marinis JM, Lich JD, Berger SB, Chirala A, Cox JA, Eidam PM, Finger JN, Gough PJ, Jeong JU et al.. (2019)
Identification of a RIP1 Kinase Inhibitor Clinical Candidate (GSK3145095) for the Treatment of Pancreatic Cancer.
ACS Med Chem Lett, 10 (6): 857-862. [PMID:31223438]